New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 28, 2014
17:46 EDTANTHAnthera Pharmaceuticals reports Q2 EPS (34c), consensus (49c)
As of June 30, the company's cash, cash equivalents and restricted cash was $22.8M, compared to $35.9M at December 31, 2013.
News For ANTH From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
December 15, 2014
09:12 EDTANTHAnthera Pharmaceuticals licenses Japan rights for blisibimod
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use